Summary

Global Respiratory Care Devices Market Size

Respiratory Care Devices Market is expected to reach US$ 49.19 billion in 2033 from US$ 24.17 billion in 2024, with a CAGR of 8.22% from 2025 to 2033. The introduction of small devices and the increased prevalence of lung cancer and other serious respiratory diseases are the main factors propelling the market's expansion.


Respiratory Care Devices Industry Overview

Medical equipment known as respiratory care devices is used to treat or manage respiratory diseases such pneumonia, sleep apnea, COPD, and asthma. These tools support healthy lung function, oxygen levels, and airflow. Common varieties include CPAP machines, which treat sleep apnea by maintaining constant airflow; oxygen concentrators, which supply extra oxygen; nebulizers, which administer medication through a mist; and ventilators, which aid with breathing. These gadgets are now more effective, portable, and easy to use thanks to technological advancements. The need for respiratory care equipment is increasing worldwide due to an aging population, air pollution, and an increase in respiratory disease incidence.

The growing incidence of respiratory conditions including asthma, COPD, and sleep apnea, especially as a result of aging populations and unhealthy lifestyles, is one of the major drivers propelling the market for respiratory care equipment. Technology breakthroughs and heightened awareness of respiratory health have resulted in more effective, portable, and user-friendly equipment. Additionally, the need for respiratory care is rising due to environmental causes and rising air pollution levels. Government programs to enhance respiratory care and the expansion of healthcare infrastructure, particularly in emerging nations, are important factors driving market growth. The demand for respiratory care devices is driven by all of these causes together.


Growth Drivers for the Respiratory Care Devices Market

Growing Government Initiatives

Globally, governments are acting to enhance access to respiratory treatment and address the growing prevalence of respiratory illnesses. The demand for the respiratory market is also being increased by the introduction of regulations by regulatory organizations in different nations that are intended to enhance the prevention, diagnosis, and treatment of respiratory disorders. To assist healthcare facilities in putting respiratory protection programs into place, the Centers for Disease Control and Prevention (CDC) created the Hospital Respiratory Protection Program Toolkit. The toolkit offers instructions on how to set up and keep up a thorough respiratory protection program to shield medical staff members from influenza and TB. To lower the prevalence of respiratory illnesses, government agencies are also starting vaccine campaigns, smoking cessation programs, and pollution control initiatives.


Increasing Respiratory Disease Prevalence

Asthma, sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions are serious global health concerns that impact people all over the world. The need for respiratory care equipment is being driven by the rising incidence of chronic illnesses, the aging population, rising air pollution, and changing lifestyles.

The National Center for Health Statistics reports that in 2022, approximately 4.6% of American adults had a diagnosis of chronic bronchitis, emphysema, or chronic obstructive pulmonary disease (COPD). Additionally, the WHO report from 2023 states that asthma afflicted 262 million people and resulted in 45,5000 fatalities. In order to effectively manage and treat respiratory disorders, respiratory care equipment are essential. For patients with respiratory disorders, these devices assist improve lung function, reduce symptoms, and improve their quality of life. In addition, it is anticipated that the need for respiratory care equipment would increase in the upcoming years due to the increased prevalence of unhealthy lifestyles, alcohol consumption, and chain smoking.


Growing Number of Elderly People

Respiratory diseases include pneumonia, sleep apnea, and chronic obstructive pulmonary disease (COPD) are more common in the elderly population. The World Health Organization (WHO), for example, predicts that by 2030, one in sixty persons worldwide would be 60 years of age or older. By 2050, there will be more elderly people worldwide. Elderly people are especially vulnerable to respiratory problems because aging can weaken the respiratory muscles and decrease lung function. Nebulizers, CPAP machines, and oxygen therapy devices are examples of respiratory care devices that are frequently used to treat respiratory disorders in the senior population.

Additionally, manufacturers are creating cutting-edge devices, like portable, user-friendly devices that can be utilized at home, to cater to the unique demands of senior people. For example, in November 2022, Xplore Health Technologies unveiled the Airofit Pro, a ground-breaking respiratory muscle training (RMT) tool.


Challenges in the Respiratory Care Devices Market

Maintainance and Training

In the market for respiratory care devices, maintenance and training present major obstacles. To guarantee optimum performance, many devices—including oxygen concentrators, CPAP machines, and ventilators—need routine maintenance, which can be expensive and time-consuming. Furthermore, in order to use these devices correctly, particularly in emergency situations or home care settings, patients and healthcare personnel frequently require specialized training. Patient outcomes may be impacted by inappropriate use brought on by inadequate training. Maintaining appropriate care and training for patients and healthcare workers continues to be a major concern, especially in developing nations with little access to resources and knowledge.


Regulatory Obstacle

In the market for respiratory care devices, regulatory obstacles pose a serious problem. The FDA, EMA, and other regulatory bodies have specific rules that must be followed during the lengthy and complicated approval procedure for medical devices. Comprehensive clinical trials, quality assurance procedures, and safety testing are all part of these rules. Manufacturers may incur more costs and postpone product launches in order to meet these standards. In addition, differing national laws may make it more difficult to enter international markets and impede the expansion of respiratory care device manufacturers.


The pulse oximetry market is projected to grow in the upcoming years

The pulse oximetry market is poised for enduring expansion in healthcare technology because it traverses the forecast period. This sector plays a pivotal role in monitoring oxygen levels in patients, with its demand displaying no signs of slowing down. The continual growth displays the growing importance of pulse oximeters in clinical and home settings, as they offer essential data for respiratory health.

As this vital sector progresses, it offers promising potentialities for companies and buyers within the healthcare industry. As an instance, consistent with records from clinicaltrials.gov, the study supported RaydiantOximetry, Inc., which started in July 2022 and is projected to conclude in December 2023. The RaydiantOximetry Sensing System, known as Lumerah, is a non-invasive fetal pulse oximeter designed for measuring fetal arterial oxygen saturation via secure and non-invasive transabdominal close-to-infrared spectroscopy.

Therapeutic respiratory devices are vital in treating respiration situations, presenting crucial remedies, and raising patients' standard, high-quality lifestyles

Therapeutic respiratory devices stand as indispensable equipment in the management of respiratory conditions. These devices play a pivotal role in alleviating breathing problems, imparting a lifeline to people grappling with chronic obstructive pulmonary sickness (COPD), bronchial asthma, or even acute respiratory distress. These treatments facilitate stepped-forward airflow through mechanisms like nebulizers, inhalers, and acceptable airway pressure devices, making each breath more effortless. This, in turn, translates into a remarkable enhancement in the overall quality of lifestyles for patients, letting them interact in day-by-day activities with increased comfort and independence, a true testament to the importance of these life-enhancing medical devices.


Oxygen Concentrates thrive in the respiratory care device market

The Oxygen Concentrators market is a pivotal sector within the expansive realm of the Respiratory Care Device industry. These devices have profoundly impacted the lives of individuals with numerous respiratory situations, including chronic obstructive pulmonary disease (COPD), asthma, and many more.

Oxygen concentrators are instrumental in delivering reliable and continuous oxygen to patients, changing the need for traditional oxygen tanks. Their convenience, cost-effectiveness, and sustainability make them increasingly essential in healthcare settings and at home. With the prevalence of respiration illnesses growing, the oxygen concentrator market is poised for continued demand, promising improved quality of life for countless patients.


The healthcare facility sector, particularly hospitals, held the predominant market share in the Respiratory Care Device industry

In the dynamic landscape of the Respiratory Care Device industry, hospitals emerged as the undisputed leaders, commanding the market with authority. Their dominance is rooted in their pivotal role as primary healthcare providers, where various respiratory conditions are diagnosed and treated. Hospitals utilize an array of respiratory care devices, from ventilators to oxygen concentrators, to ensure the well-being of patients. This extensive application of respiratory care technology solidifies their prominence. Furthermore, their advanced infrastructure, skilled healthcare professionals, and comprehensive approach to respiratory health cement hospitals as the industry's epicenter of innovation and care.


Respiratory Care Devices Market Overview by Regions

The demand for respiratory care equipment is high in North America, Europe, and Asia-Pacific, and the market is expanding globally. While Asia-Pacific has significant growth due to rising respiratory diseases and better access to healthcare, North America leads due to its sophisticated healthcare infrastructure. Global players have the opportunity to expand in emerging markets.


United States Respiratory Care Devices Market

The rising incidence of respiratory conditions like asthma, COPD, and sleep apnea is fueling the market for respiratory care equipment in the US. Accessibility and patient outcomes have been enhanced by technological developments in equipment including oxygen concentrators, CPAP machines, and ventilators. Increased air pollution, growing respiratory health consciousness, and an aging population all support the market's growth. The growth of healthcare infrastructure and government programs also encourage the use of respiratory care devices. The increasing popularity of remote patient monitoring and home healthcare, which give patients convenient treatment alternatives, is further driving demand.

The United States will invest USD 150 million in research and development for respiratory disorders in 2022, including COPD (USD 150 million), asthma (USD 328 million), tuberculosis (USD 621 million), and sleep research (USD 515 million), according to the NIH's May 2022 report.Thus, it is anticipated that increased investment in respiratory illness research will spur the country's development of novel respiratory devices, which will further support market expansion throughout the projection period.


Germany Respiratory Care Devices Market

Due to the high frequency of respiratory conditions including asthma and COPD, the market for respiratory care equipment in Germany is growing. The need for equipment like oxygen concentrators, CPAP machines, and nebulizers is further fueled by the aging population and rising air pollution. Patient care is improved by Germany's robust healthcare system and technological developments. The market is also expanding as a result of government measures to enhance healthcare services and growing awareness of respiratory health. Germany remains a key player in the European respiratory care devices market.


India Respiratory Care Devices Market

The market for respiratory care devices in India is expanding quickly due to the increased prevalence of respiratory conditions such COPD, asthma, and respiratory infections. The need for equipment like ventilators, CPAP machines, and oxygen concentrators is rising due to factors like rising air pollution, an aging population, and increased awareness of respiratory health. Government programs and better healthcare infrastructure are also fostering industry growth. The market for respiratory care equipment in India is expanding due in part to the growing use of home healthcare services and rising disposable incomes.


UAE Respiratory Care Devices Market

The rising incidence of respiratory conditions including asthma and COPD, which are fueled by lifestyle factors and air pollution, is driving the growth of the respiratory care devices market in the United Arab Emirates. As more people use cutting-edge respiratory equipment like ventilators, CPAP machines, and oxygen concentrators, the nation's healthcare system is progressing. The growing number of older people and growing awareness of respiratory health issues also fuel market expansion. The UAE is a sizable market in the Middle East due to government efforts to upgrade healthcare infrastructure and a move toward home healthcare services, which are increasing demand for respiratory care devices.


Device Type – Market has been covered from 4 viewpoints
1. Therapeutic Devices
2. Monitoring Devices
3. Diagnostic Devices
4. Consumables & Accessories


Products – Market has been covered from 8 viewpoints
1. Respiratory Consumables
2. Nebulizers
3. Oxygen Concentrators
4. Polysomnography Devices
5. Pulse Oximeter
6. Mechanical Ventilators
7. Spirometers
8. Others


Application – Market has been covered from 6 viewpoints
1. Chronic Obstructive Pulmonary Disease (COPD)
2. Obstructive Sleep Apnea
3. Asthma
4. Respiratory Distress Syndrome
5. Cystic Fibrosis
6. Others


End Users – Market has been covered from 3 viewpoints
1. Hospitals
2. Home Care
3. Ambulatory Care


Country – This report covers the 18 countries
1. North America
1.1 United States
1.2 Canada
2. Latin America
2.1 Mexico
2.2 Brazil
3. Europe
3.1 United Kingdom
3.2 Germany
3.3 France
3.4 Italy
3.5 Spain
3.6 Netherlands
4. Asia Pacific
4.1 China
4.2 Japan
4.3 India
4.4 South Korea
4.5 Australia
5. Middle East & Africa
5.1 United Arab Emirates
5.2 South Africa
6. Rest of the World


All the companies have been studied from 3 points
• Business Overview
• Recent Developments
• Sales Analysis


Company Analysis
1. Medtronic Plc
2. Koninklijke Philips
3. General Electric Company
4. Masimo Corporation
5. ResMed Inc.
6. Becton Dickinson
7. Chart Industries Inc.
8. Getinge AB
9. InogenInc


Key Questions Answered in Report:

1. How big is the respiratory care devices industry?
The global respiratory care devices market size was valued at US$ 24.16 billion in 2024 and is expected to reach US$ 49.19 billion in 2033.

2. What is the respiratory care devices growth rate?
The global respiratory care devices market is expected to expand at a compound annual growth rate (CAGR) of 8.22% from 2025 to 2033.

3. Who are the key players in respiratory care devices industry?
The competitive landscape includes Medtronic P.C., Koninclick-Phillips, General Electric Company, Masimo Corporation, ResMed Inc., Becton Dickinson, Chart Industries Inc., Gettinge AB, and Inogen Inc.

4. What are the factors driving the respiratory care devices industry?
Growth drivers of the respiratory care devices market include rising respiratory diseases, aging populations, increased air pollution, technological advancements, growing healthcare infrastructure, and higher awareness of respiratory health and early diagnosis.

5. Which Region held the largest market share in the respiratory care devices industry?
North America is expected to hold the largest market share in the industry.

6. What segments are covered in the respiratory care devices market report?
Device Type, Product, Application, End Users and Countries segment are covered in this report.

ページTOPに戻る

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

4.1 Drivers
4.2 Restraints


5. Global Respiratory Care Devices Market

6. Market Share Analysis

6.1 By Application
6.2 By Device Types
6.3 By Product Type
6.4 By End Users
6.5 By Country


7. Application

7.1 Chronic Obstructive Pulmonary Disease (COPD)
7.2 Obstructive Sleep Apnea
7.3 Asthma
7.4 Respiratory Distress Syndrome
7.5 Cystic Fibrosis
7.6 Others


8. Device Type

8.1 Therapeutic Devices
8.2 Monitoring Devices
8.3 Diagnostic Devices
8.4 Consumables & Accessories


9. Product Type

9.1 Respiratory Consumables
9.2 Nebulizers
9.3 Oxygen Concentrators
9.4 Polysomnography Devices
9.5 Pulse Oximeter
9.6 Mechanical Ventilators
9.7 Spirometers
9.8 Others


10. End Users

10.1 Hospitals
10.2 Home Care
10.3 Ambulatory Care


11. Country

11.1 North America

11.1.1 United States
11.1.2 Canada

11.2 Latin America

11.2.1 Mexico
11.2.2 Brazil

11.3 Europe

11.3.1 United Kingdom
11.3.2 Germany
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 Netherlands

11.4 Asia Pacific

11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Australia

11.5 Middle East & Africa

11.5.1 United Arab Emirates
11.5.2 South Africa

11.6 Rest of the World


12. Porter’s Five Forces Analysis

12.1 Bargaining Power of Buyers
12.2 Bargaining Power of Suppliers
12.3 Degree of Rivalry
12.4 Threat of New Entrants
12.5 Threat of Substitutes


13. SWOT Analysis

13.1 Strength
13.2 Weakness
13.3 Opportunity
13.4 Threat


14. Company Analysis

14.1 Medtronic Plc

14.1.1 Overview
14.1.2 Initiatives & Strategy
14.1.3 Revenue

14.2 Koninklijke Philips

14.2.1 Overview
14.2.2 Initiatives & Strategy
14.2.3 Revenue

14.3 General Electric Company

14.3.1 Overview
14.3.2 Initiatives & Strategy
14.3.3 Revenue

14.4 Masimo Corporation

14.4.1 Overview
14.4.2 Initiatives & Strategy
14.4.3 Revenue

14.5 ResMedInc

14.5.1 Overview
14.5.2 Initiatives & Strategy
14.5.3 Revenue

14.6 Becton Dickinson

14.6.1 Overview
14.6.2 Initiatives & Strategy
14.6.3 Revenue

14.7 Chart Industries Inc

14.7.1 Overview
14.7.2 Initiatives & Strategy
14.7.3 Revenue

14.8 Getinge AB

14.8.1 Overview
14.8.2 Initiatives & Strategy
14.8.3 Revenue

14.9 Inogen Inc.

14.9.1 Overview
14.9.2 Initiatives & Strategy
14.9.3 Revenue